Ma-Weaver Jacob 13D and 13G filings for ARCA biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-05-27 4:40 pm Purchase |
2022-05-25 | 13D | ARCA biopharma, Inc. ABIO |
Ma-Weaver Jacob | 215,038 17.910% |
215,038 (New Position) |
Filing |